Intraoperative Pain After Infiltration Technique Using Artpharma Versus Artinibsa in Children

计划入组 130 人 · 首次发布于 2020 年 1 月 9 日

Assess Intraoperative Pain for Restorative Treatment of Maxillary 1st Permanent Molars Using Artinibsa Versus Artpharma in Children During Infiltration Technique

计划入组 46 人 · 首次发布于 2020 年 3 月 11 日

Recombinant pseudoadenoviral influenza vaccine(NantPharma LLC)

Recombinant pseudoadenoviral lactoferrin gene therapy(NantPharma LLC)

Recombinant pseudoadenoviral VEGF/ANG gene therapy(NantPharma LLC)

Nantpharma, LLC

United States

NEXTPHARMA PLOERMEL

France

NEXTPHARMA SAS

France

Oncotelic Therapeutics Advances Clinical Pipeline Led by CEO's $4.2B Patent Legacy

Defence Therapeutics Strengthens Leadership with Quality Operations Expert to Advance ADC Platform